{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:53Z","timestamp":1792800713949,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UG1DA050067-04"],"award-info":[{"award-number":["5UG1DA050067-04"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Implementation of medications for opioid use disorder (MOUD) in jails varies by facility and across states. Organizational climate, including staff attitudes toward change and exposure to education, can influence perceptions of innovations like MOUD in jails. Using a mixed methods design, we aimed to understand the association between organizational climate and jail staff perceptions of MOUD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Jail staff (n\u2009=\u2009111) who operate MOUD programs in 6 Massachusetts jails completed surveys that included the Organizational Readiness for Implementing Change (ORIC) survey. Random effects logistic regression models assessed associations between organizational climate and several outcomes of perceived MOUD efficacy, acceptability, and knowledge, while controlling for covariates. Jail staff (N\u2009=\u200961) participated in qualitative interviews and focus groups focused on organizational climate and knowledge diffusion, which we analyzed using inductive and deductive methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results indicate that organizational change readiness on the ORIC was associated with positive perceptions of MOUD, and educational resources facilitated MOUD implementation. Greater ORIC was associated with higher perception of methadone as highly acceptable for jail populations (Odds ratio [OR] 2.3, 95% Confidence Interval [CI] 1.2 to 4.4), and high knowledge of methadone (OR 2.3, 95% CI 1.1 to 4.9), with similar magnitude of effects for buprenorphine. High levels of training for jail staff on methadone and buprenorphine were also associated with higher knowledge of these medications (Methadone: OR 7.2, 95% CI 2.2 to 23.2; Buprenorphine: OR 3.4, 95% CI 1.2 to 9.5). Qualitative results point towards the importance of organizational climate and elucidate educational strategies to improve staff perceptions of MOUD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Results underscore the importance of organizational climate for successful implementation of jail MOUD programs and provide support for medication-specific educational resources as a facilitator of successful MOUD implementation in jail settings. Findings highlight implementation strategies that may improve jail staff perceptions of MOUD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-024-00440-2","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T15:04:53Z","timestamp":1707750293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-0849","authenticated-orcid":false,"given":"Pryce S.","family":"Michener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"440_CR1","unstructured":"Ahmad F, Rossen L, Sutton P. National Center for Health Statistics. 2023. Provisional drug overdose death counts. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm Accessed 5 Mar 2023"},{"key":"440_CR2","doi-asserted-by":"crossref","unstructured":"Rao IJ, Humphreys K, Brandeau ML. Effectiveness of policies for addressing the US opioid epidemic: a model-based analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. The Lancet Regional Health\u2013Americas. 2021. https:\/\/www.thelancet.com\/journals\/lanam\/article\/PIIS2667-193X(21)00023-5\/fulltext Accessed 3 Feb 2022","DOI":"10.1016\/j.lana.2021.100031"},{"issue":"2","key":"440_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison\u2013a high risk of death for former inmates. N Engl J Med. 2007;356(2):157\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"440_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17.","journal-title":"Addict Sci Clin Pract"},{"issue":"9","key":"440_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592\u2013600.","journal-title":"Ann Intern Med"},{"issue":"357","key":"440_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"26","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;26(357): j1550.","journal-title":"BMJ"},{"issue":"12","key":"440_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003002","volume":"16","author":"M Malta","year":"2019","unstructured":"Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B. Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review. PLoS Med. 2019;16(12): e1003002.","journal-title":"PLoS Med"},{"issue":"18","key":"440_CR8","volume":"1","author":"RA Martin","year":"2023","unstructured":"Martin RA, Alexander-Scott N, Berk J, Carpenter RW, Kang A, Hoadley A, et al. Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: a retrospective cohort study. Lancet Reg Health Am. 2023;1(18): 100419.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"440_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1353\/hpu.2022.0031","volume":"33","author":"H Neill-Gubitz","year":"2022","unstructured":"Neill-Gubitz H, Graves JM, Barbosa-Leiker C. Availability of health care services and medications for opioid use disorder in carceral facilities in Washington, Oregon, and Idaho. J Health Care Poor Underserved. 2022;33(1):407\u201318.","journal-title":"J Health Care Poor Underserved"},{"issue":"1","key":"440_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44369","volume":"5","author":"C Sufrin","year":"2022","unstructured":"Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, et al. Availability of medications for the treatment of opioid use disorder among pregnant and postpartum individuals in US jails. JAMA Netw Open. 2022;5(1): e2144369.","journal-title":"JAMA Netw Open"},{"key":"440_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108275","volume":"128","author":"EA Evans","year":"2021","unstructured":"Evans EA, Stopka TJ, Pivovarova E, Murphy SM, Taxman FS, Ferguson WJ, et al. Massachusetts justice community opioid innovation network (MassJCOIN). J Subst Abuse Treat. 2021;128: 108275.","journal-title":"J Subst Abuse Treat"},{"key":"440_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108746","volume":"23","author":"EA Evans","year":"2022","unstructured":"Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022;23: 108746.","journal-title":"J Subst Abuse Treat"},{"issue":"109","key":"440_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103823","volume":"1","author":"A Matsumoto","year":"2022","unstructured":"Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, et al. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022;1(109): 103823.","journal-title":"Int J Drug Policy"},{"issue":"234","key":"440_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109394","volume":"1","author":"E Pivovarova","year":"2022","unstructured":"Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: a qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022;1(234): 109394.","journal-title":"Drug Alcohol Depend"},{"issue":"110","key":"440_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103803","volume":"1","author":"TJ Stopka","year":"2022","unstructured":"Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD, et al. Medication for opioid use disorder treatment continuity post-release from jail: a qualitative study with community-based treatment providers. Int J Drug Policy. 2022;1(110): 103803.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"440_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2307\/259164","volume":"21","author":"KJ Klein","year":"1996","unstructured":"Klein KJ, Sorra JS. The challenge of innovation implementation. Acad Manag Rev. 1996;21(4):1055\u201380.","journal-title":"Acad Manag Rev"},{"key":"440_CR17","first-page":"550","volume-title":"Diffusion of Innovations","author":"EM Rogers","year":"2010","unstructured":"Rogers EM. Diffusion of Innovations. 4th ed. New York City: Simon and Schuster; 2010. p. 550.","edition":"4"},{"issue":"7","key":"440_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40352-019-0100-2","volume":"12","author":"WJ Ferguson","year":"2019","unstructured":"Ferguson WJ, Johnston J, Clarke JG, Koutoujian PJ, Maurer K, Gallagher C, et al. Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails. Health Justice. 2019;12(7):19.","journal-title":"Health Justice"},{"issue":"7","key":"440_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10597-013-9668-5","volume":"50","author":"AE Green","year":"2014","unstructured":"Green AE, Albanese BJ, Cafri G, Aarons GA. Leadership, organizational climate, and working alliance in a children\u2019s mental health service system. Community Ment Health J. 2014;50(7):771\u20137.","journal-title":"Community Ment Health J"},{"issue":"4","key":"440_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.0887-378X.2004.00325.x","volume":"82","author":"T Greenhalgh","year":"2004","unstructured":"Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82(4):581\u2013629.","journal-title":"Milbank Q"},{"issue":"6","key":"440_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/job.162","volume":"23","author":"C Glisson","year":"2002","unstructured":"Glisson C, James LR. The cross-level effects of culture and climate in human service teams. J Organ Behav. 2002;23(6):767\u201394.","journal-title":"J Organ Behav"},{"issue":"1","key":"440_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1748-5908-4-67","volume":"4","author":"BJ Weiner","year":"2009","unstructured":"Weiner BJ. A theory of organizational readiness for change. Implement Sci. 2009;4(1):67.","journal-title":"Implement Sci"},{"issue":"9","key":"440_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1748-5908-9-7","volume":"10","author":"CM Shea","year":"2014","unstructured":"Shea CM, Jacobs SR, Esserman DA, Bruce K, Weiner BJ. Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci. 2014;10(9):7.","journal-title":"Implement Sci"},{"issue":"4","key":"440_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jsat.2013.12.007","volume":"46","author":"B Hartzler","year":"2014","unstructured":"Hartzler B, Jackson TR, Jones BE, Beadnell B, Calsyn DA. Disseminating contingency management: impacts of staff training and implementation at an opiate treatment program. J Subst Abuse Treat. 2014;46(4):429\u201338.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"440_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/hsw\/hlz014","volume":"44","author":"A Iachini","year":"2019","unstructured":"Iachini A, Seay K, DeHart D, Petiwala A, Browne T. Process and product innovations from a statewide capacity-building initiative for substance use treatment and recovery. Health Soc Work. 2019;44(3):167\u201375.","journal-title":"Health Soc Work"},{"issue":"2","key":"440_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jsat.2005.05.002","volume":"29","author":"HK Knudsen","year":"2005","unstructured":"Knudsen HK, Ducharme LJ, Roman PM, Link T. Buprenorphine diffusion: the attitudes of substance abuse treatment counselors. J Subst Abuse Treat. 2005;29(2):95\u2013106.","journal-title":"J Subst Abuse Treat"},{"key":"440_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146","volume":"119","author":"K Cioe","year":"2020","unstructured":"Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119: 108146.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"440_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1057\/biosoc.2015.46","volume":"12","author":"J Netherland","year":"2017","unstructured":"Netherland J, Hansen H. White opioids: Pharmaceutical race and the war on drugs that wasn\u2019t. BioSocieties. 2017;12(2):217\u201338.","journal-title":"BioSocieties"},{"issue":"6","key":"440_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1521-0391.2010.00086.x","volume":"19","author":"I Maremmani","year":"2010","unstructured":"Maremmani I, Gerra G. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment. Am J Addict. 2010;19(6):557\u201368.","journal-title":"Am J Addict"},{"issue":"12","key":"440_CR30","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1080\/10826084.2022.2115853","volume":"57","author":"E Pasman","year":"2022","unstructured":"Pasman E, Lee G, Kollin R, Rodriguez B, Agius E, Madden EF, et al. Attitudes toward medication for opioid use disorder among substance use treatment providers. Subst Use Misuse. 2022;57(12):1828\u201336.","journal-title":"Subst Use Misuse"},{"key":"440_CR31","unstructured":"Creswell JW, Creswell JD. Research design: qualitative, quantitative, and mixed methods approaches. SAGE Publications; 2018. 304."},{"key":"440_CR32","unstructured":"Prendergast M, Shafer M, Frisman L, Visher C, Leukefeld C, Sacks S, et al. Criminal justice drug abuse treatment studies (CJ-DATS) 2: organizational process improvement intervention (OPII), 2010\u20132013 [United States]: Version 2. ICPSR\u2013Interuniversity Consortium for Political and Social Research; 2015. https:\/\/www.icpsr.umich.edu\/web\/NAHDAP\/studies\/35082\/versions\/V2. Accessed 23 Oct 2023"},{"issue":"6","key":"440_CR33","first-page":"1887","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Li\u015bkiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019 Int J Epidemiol. 2016;45(6):1887\u201394.","journal-title":"Int J Epidemiol"},{"issue":"142","key":"440_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jclinepi.2021.08.001","volume":"1","author":"JC Digitale","year":"2022","unstructured":"Digitale JC, Martin JN, Glymour MM. Tutorial on directed acyclic graphs. J Clin Epidemiol. 2022;1(142):264\u20137.","journal-title":"J Clin Epidemiol"},{"key":"440_CR35","unstructured":"StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC; 2017."},{"issue":"1","key":"440_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","volume":"38","author":"GA Aarons","year":"2011","unstructured":"Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4\u201323.","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"440_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/10550887.2012.694599","volume":"31","author":"JS Woods","year":"2012","unstructured":"Woods JS, Joseph H. Reducing stigma through education to enhance Medication-Assisted Recovery. J Addict Dis. 2012;31(3):226\u201335.","journal-title":"J Addict Dis"},{"issue":"2","key":"440_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jsat.2006.12.022","volume":"33","author":"DD Simpson","year":"2007","unstructured":"Simpson DD, Joe GW, Rowan-Szal GA. Linking the elements of change: program and client responses to innovation. J Subst Abuse Treat. 2007;33(2):201\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"103 Suppl 1","key":"440_CR39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.drugalcdep.2009.03.003","volume":"1","author":"FS Taxman","year":"2009","unstructured":"Taxman FS, Henderson CE, Belenko S. Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system. Drug Alcohol Depend. 2009;1(103 Suppl 1):S1-6.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"440_CR40","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1111\/add.15565","volume":"116","author":"S Bandara","year":"2021","unstructured":"Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters. Addiction. 2021;116(12):3473\u201381.","journal-title":"Addiction"},{"issue":"1","key":"440_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40352-022-00197-3","volume":"10","author":"CK Scott","year":"2022","unstructured":"Scott CK, Grella CE, Dennis ML, Carnevale J, LaVallee R. Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S. Health Justice. 2022;10(1):36.","journal-title":"Health Justice."},{"issue":"1","key":"440_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/1475-6773.12093","volume":"49","author":"CJ Heinrich","year":"2014","unstructured":"Heinrich CJ, Cummings GR. Adoption and diffusion of evidence-based addiction medications in substance abuse treatment. Health Serv Res. 2014;49(1):127\u201352.","journal-title":"Health Serv Res"},{"key":"440_CR43","unstructured":"Center for translational data science. JCOIN Data Commons. University of Chicago: Gen3 Data Commons; 2023. https:\/\/jcoin.datacommons.io\/ Accessed 26 Apr 2023"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00440-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T15:09:20Z","timestamp":1707750560000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00440-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00440-2","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Baystate Medical Center Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}